Showing results (1-10 of 2,577) with videos related to
Sort By:
Pageof 258
Biochimica Et Biophysica Acta. Reviews on Cancer|March 22, 2026
Targeting BATF: A new strategy for cancer immunotherapyLinyang Li, Xuwen Lin, Qun Wang, et al.Acta Biochimica Et Biophysica Sinica|June 3, 2024
Posttranslational regulatory mechanism of PD-L1 in cancers and associated opportunities for novel small-molecule therapeuticsMinchen Cai, Mengting Xu, Dianping Yu, et al.The Journal of Clinical Investigation|February 2, 2026
Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of LKB1 and SYVN1Mengting Xu, Xuwen Lin, Hanchi Xu, et al.Cell Reports. Medicine|July 13, 2026
Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitinationXuwen Lin, Qun Wang, Mengting Xu, et al.Acta Biochimica Et Biophysica Sinica|July 6, 2023
Molecular mechanisms of ferroptosis and its antitumor applications in natural productsDianping Yu, Qun Wang, Qing Zhang, et al.Medcomm|October 20, 2025
Cordycepin Targets HRD1 to Promote Cancer Cell PD-L1 Ubiquitin-Proteasome Degradation and Increase Antitumor ImmunityXiangxin Geng, Minchen Cai, Hongmei Hu, et al.Medcomm|June 28, 2024
5,7,4'-Trimethoxyflavone triggers cancer cell PD-L1 ubiquitin-proteasome degradation and facilitates antitumor immunity by targeting HRD1Jianhua Xia, Mengting Xu, Hongmei Hu, et al.Acta Pharmaceutica Sinica. B|November 11, 2024
Demethylzeylasteral induces PD-L1 ubiquitin-proteasome degradation and promotes antitumor immunity <i>via</i> targeting USP22Yanyan Zhang, Yun Huang, Dianping Yu, et al.Journal of Medicinal Chemistry|March 13, 2026
Chemical Space Navigation of Nitidine Leads to the Discovery of a Novel PD-L1 Degradation Agent by Targeting CSN5 for Enhanced Antitumor ImmunityQun Wang, Mengmeng Guo, Yujia Song, et al.Signal Transduction and Targeted Therapy|July 6, 2025
Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1/2 and GPX4 in colorectal cancerDianping Yu, Hongmei Hu, Qing Zhang, et al.Pageof 258